IMMUNITAS
Live / Registered — Registered (as of 07 Feb 2023)
What this means for you
Registered since 07 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88984873
- Registration number
- 6975007
- Mark type
- Stylized text
- Filed
- 18 Dec 2019
- Published for opposition
- 28 Apr 2020
- Registered
- 07 Feb 2023
- Attorney of record
- Joshua Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders
Owner
- Immunitas Therapeutics, Inc., Waltham, MA, US
- Immunitas Therapeutics, Inc., Waltham, MA, US
- Immunitas Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 07 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 03 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Dec 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Dec 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Dec 2022 — USE AMENDMENT FILED
- 29 Dec 2022 — DIVISIONAL PROCESSING COMPLETE
- 01 Dec 2022 — DIVISIONAL REQUEST RECEIVED
- 29 Dec 2022 — SOU EXTENSION 5 GRANTED
- 01 Dec 2022 — SOU EXTENSION 5 FILED
- 29 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Dec 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 01 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Dec 2022 — TEAS STATEMENT OF USE RECEIVED